Print Friendly, PDF & Email

NCT/Study#

NCT04728893 /

MK-1026-003

A Phase 2 Study To Evaluate The Efficacy And Safety Of MK-1026 In Participants With Hematologic Malignancies

DISEASE GROUP:

Lymphoma

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587